Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Ani Pharmaceuticals (ANIP) over the last 16 years, with Dec 2024 value amounting to -$1.04.

  • Ani Pharmaceuticals' EPS (Weighted Average and Diluted) rose 188.98% to $1.13 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.63, marking a year-over-year increase of 385.96%. This contributed to the annual value of -$1.04 for FY2024, which is 222.35% down from last year.
  • Ani Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to -$1.04 in FY2024, which was down 222.35% from $0.85 recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of $0.85 during FY2023, and its lowest value of -$3.40 during FY2021.
  • Over the past 3 years, Ani Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$1.04 (recorded in 2024), while the average stood at -$1.08.
  • In the last 5 years, Ani Pharmaceuticals' EPS (Weighted Average and Diluted) crashed by 476.00% in 2020 and then spiked by 127.87% in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' EPS (Weighted Average and Diluted) (Yearly) stood at -$1.88 in 2020, then crashed by 80.85% to -$3.40 in 2021, then increased by 10.29% to -$3.05 in 2022, then surged by 127.87% to $0.85 in 2023, then slumped by 222.35% to -$1.04 in 2024.